Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on November 25, 2008
JNCI Journal of the National Cancer Institute 2008 100(23):1739; doi:10.1093/jnci/djn395
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/23/1739    most recent
djn395v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Field, K. M.
Right arrow Articles by Gibbs, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Field, K. M.
Right arrow Articles by Gibbs, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Re: Residual Treatment Disparities After Oncology Referral for Rectal Cancer

Kathryn M. Field, Suzanne Kosmider, Jayesh Desai, Lionel C. Lim, Frances S. Barnett, Stephen McLaughlin, Ian T. Jones, Peter Gibbs

Affiliations of authors: Department of Medical Oncology (KMF, SK, JD, LCL, FSB, PG) and Department of Surgery (ITJ), Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Medical Oncology (KMF, SK, JD, LCL, FSB, PG) and Department of Surgery (SM), Western Hospital, Melbourne, Victoria, Australia; BioGrid Australia (KMF, SK, PG) and Ludwig Institute for Cancer Research (PG), Parkville, Melbourne, Victoria, Australia

Correspondence to: Kathryn M. Field, MBBS (Hons), FRACP, BioGrid Australia, Royal Melbourne Hospital, Royal Parade, Parkville, Victoria 3050, Australia (e-mail: kathryn.field@mh.org.au).

The first 10% of the full text of this article appears below.

The recent article by Morris et al. (1) is of interest. Their analysis of Surveillance, Epidemiology, and End Results (SEER) data produced an unexpected finding that disparities between black and white patients in the use of adjuvant treatment for rectal cancer were seen particularly in younger and fitter patients. Although a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The OncologistHome page
M. Moore, S. Kosmider, K. Field, J. Desai, L. Lim, F. Barnett, and P. Gibbs
Response to "Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting"
Oncologist, January 1, 2009; 14(1): 104 - 105.
[Full Text] [PDF]